Cargando…
Posterior scleritis after biweekly aflibercept intravitreal injections
PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474326/ https://www.ncbi.nlm.nih.gov/pubmed/36118279 http://dx.doi.org/10.1016/j.ajoc.2022.101696 |
_version_ | 1784789691953840128 |
---|---|
author | Hébert, Mélanie You, Eunice Gravel, Jean-François Dirani, Ali Bourgault, Serge |
author_facet | Hébert, Mélanie You, Eunice Gravel, Jean-François Dirani, Ali Bourgault, Serge |
author_sort | Hébert, Mélanie |
collection | PubMed |
description | PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe pain, photophobia, and tearing. Ophthalmological examination revealed choroidal folds and B-scan ultrasound confirmed significant thickening of the sclera, leading to a diagnosis of posterior scleritis. This resolved under topical and systemic corticosteroids. CONCLUSIONS AND IMPORTANCE: Intravitreal anti-VEGF injections could be associated with non-infectious posterior scleritis. Clinicians should be particularly aware of this possibility in patients receiving frequent injections. |
format | Online Article Text |
id | pubmed-9474326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94743262022-09-16 Posterior scleritis after biweekly aflibercept intravitreal injections Hébert, Mélanie You, Eunice Gravel, Jean-François Dirani, Ali Bourgault, Serge Am J Ophthalmol Case Rep Case Report PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe pain, photophobia, and tearing. Ophthalmological examination revealed choroidal folds and B-scan ultrasound confirmed significant thickening of the sclera, leading to a diagnosis of posterior scleritis. This resolved under topical and systemic corticosteroids. CONCLUSIONS AND IMPORTANCE: Intravitreal anti-VEGF injections could be associated with non-infectious posterior scleritis. Clinicians should be particularly aware of this possibility in patients receiving frequent injections. Elsevier 2022-09-06 /pmc/articles/PMC9474326/ /pubmed/36118279 http://dx.doi.org/10.1016/j.ajoc.2022.101696 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Hébert, Mélanie You, Eunice Gravel, Jean-François Dirani, Ali Bourgault, Serge Posterior scleritis after biweekly aflibercept intravitreal injections |
title | Posterior scleritis after biweekly aflibercept intravitreal injections |
title_full | Posterior scleritis after biweekly aflibercept intravitreal injections |
title_fullStr | Posterior scleritis after biweekly aflibercept intravitreal injections |
title_full_unstemmed | Posterior scleritis after biweekly aflibercept intravitreal injections |
title_short | Posterior scleritis after biweekly aflibercept intravitreal injections |
title_sort | posterior scleritis after biweekly aflibercept intravitreal injections |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474326/ https://www.ncbi.nlm.nih.gov/pubmed/36118279 http://dx.doi.org/10.1016/j.ajoc.2022.101696 |
work_keys_str_mv | AT hebertmelanie posteriorscleritisafterbiweeklyafliberceptintravitrealinjections AT youeunice posteriorscleritisafterbiweeklyafliberceptintravitrealinjections AT graveljeanfrancois posteriorscleritisafterbiweeklyafliberceptintravitrealinjections AT diraniali posteriorscleritisafterbiweeklyafliberceptintravitrealinjections AT bourgaultserge posteriorscleritisafterbiweeklyafliberceptintravitrealinjections |